Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Rehm

Showing results (221-230 of 234) with videos related to

Pageof 24
Sort By:
Inflammopharmacology|April 27, 2018
A phase I/II randomized, controlled, clinical trial for assessment of the efficacy and safety of β-D-mannuronic acid in rheumatoid arthritis patientsHossein Ahmadi, Ahmad Reza Jamshidi, Farhad Gharibdoost, et al.
The Journal of Antimicrobial Chemotherapy|June 12, 2018
2018 update to the HIV-TRePS system: the development of new computational models to predict HIV treatment outcomes, with or without a genotype, with enhanced usability for low-income settingsAndrew D Revell, Dechao Wang, Maria-Jesus Perez-Elias, et al.
ACS Biomaterials Science & Engineering|January 13, 2021
Design and Biological Assembly of Polyester Beads Displaying Pneumococcal Antigens as Particulate VaccineMajela González-Miró, Anna-Maria Radecker, Laura M Rodríguez-Noda, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|March 6, 2021
Engineered Mycobacterium tuberculosis antigen assembly into core-shell nanobeads for diagnosis of tuberculosisNurul Syahidah Sheffee, Patricia Rubio-Reyes, Mayelin Mirabal, et al.
The Journal of Antimicrobial Chemotherapy|April 1, 2021
2021 update to HIV-TRePS: a highly flexible and accurate system for the prediction of treatment response from incomplete baseline information in different healthcare settingsAndrew D Revell, Dechao Wang, Maria-Jesus Perez-Elias, et al.
AIDS (London, England)|August 9, 2023
Long-term persistence of transcriptionally active 'defective' HIV-1 proviruses: implications for persistent immune activation during antiretroviral therapyKanal Singh, Ven Natarajan, Robin Dewar, et al.
Theranostics|April 11, 2022
Cold atmospheric plasma for preventing infection of viruses that use ACE2 for entryPeiyu Wang, Renwu Zhou, Rusen Zhou, et al.
Inflammopharmacology|January 4, 2019
International multicenter randomized, placebo-controlled phase III clinical trial of β-D-mannuronic acid in rheumatoid arthritis patientsZahra Rezaieyazdi, Abid Farooqi, Hossein Soleymani-Salehabadi, et al.
Ebiomedicine|July 3, 2015
CD8(+) T-cell Cytotoxic Capacity Associated with Human Immunodeficiency Virus-1 Control Can Be Mediated through Various Epitopes and Human Leukocyte Antigen TypesStephen A Migueles, Daniel Mendoza, Matthew G Zimmerman, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 28, 2009
Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapyJ B Dinoso, S Y Kim, A M Wiegand, et al.
Pageof 24

Showing results (221-230 of 234) with videos related to

Sort By:
Pageof 24
Inflammopharmacology|April 27, 2018
A phase I/II randomized, controlled, clinical trial for assessment of the efficacy and safety of β-D-mannuronic acid in rheumatoid arthritis patientsHossein Ahmadi, Ahmad Reza Jamshidi, Farhad Gharibdoost, et al.
The Journal of Antimicrobial Chemotherapy|June 12, 2018
2018 update to the HIV-TRePS system: the development of new computational models to predict HIV treatment outcomes, with or without a genotype, with enhanced usability for low-income settingsAndrew D Revell, Dechao Wang, Maria-Jesus Perez-Elias, et al.
ACS Biomaterials Science & Engineering|January 13, 2021
Design and Biological Assembly of Polyester Beads Displaying Pneumococcal Antigens as Particulate VaccineMajela González-Miró, Anna-Maria Radecker, Laura M Rodríguez-Noda, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|March 6, 2021
Engineered Mycobacterium tuberculosis antigen assembly into core-shell nanobeads for diagnosis of tuberculosisNurul Syahidah Sheffee, Patricia Rubio-Reyes, Mayelin Mirabal, et al.
The Journal of Antimicrobial Chemotherapy|April 1, 2021
2021 update to HIV-TRePS: a highly flexible and accurate system for the prediction of treatment response from incomplete baseline information in different healthcare settingsAndrew D Revell, Dechao Wang, Maria-Jesus Perez-Elias, et al.
AIDS (London, England)|August 9, 2023
Long-term persistence of transcriptionally active 'defective' HIV-1 proviruses: implications for persistent immune activation during antiretroviral therapyKanal Singh, Ven Natarajan, Robin Dewar, et al.
Theranostics|April 11, 2022
Cold atmospheric plasma for preventing infection of viruses that use ACE2 for entryPeiyu Wang, Renwu Zhou, Rusen Zhou, et al.
Inflammopharmacology|January 4, 2019
International multicenter randomized, placebo-controlled phase III clinical trial of β-D-mannuronic acid in rheumatoid arthritis patientsZahra Rezaieyazdi, Abid Farooqi, Hossein Soleymani-Salehabadi, et al.
Ebiomedicine|July 3, 2015
CD8(+) T-cell Cytotoxic Capacity Associated with Human Immunodeficiency Virus-1 Control Can Be Mediated through Various Epitopes and Human Leukocyte Antigen TypesStephen A Migueles, Daniel Mendoza, Matthew G Zimmerman, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 28, 2009
Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapyJ B Dinoso, S Y Kim, A M Wiegand, et al.
Pageof 24